Last update:
Weight management news
Could a once-a-day pill replace weight loss injections? Phase II oral GLP-1 drug trial shows promising results
For those scared of needles but who need GLP-1 receptor agonists to help manage their weight, there might be some good news. Researchers are testing a new oral, small-molecule GLP-1 receptor agonist called Elecoglipron, which ...
17 hours ago
0
8
Study finds exercise decreases among people taking GLP-1 medication
Adults with obesity who lost weight with glucagon-like peptide-1 (GLP-1) receptor agonist medications significantly decreased their physical activity, which is essential to protect muscle, according to a study presented at ...
10 hours ago
0
2
Testosterone alone is not a replacement for lifestyle changes in older men at risk of type 2 diabetes, new study shows
Testosterone treatment may improve body composition, glucose metabolism and sexual desire in some older men at high risk of type 2 diabetes (T2D), but the benefits require engagement in a lifestyle program, according to a ...
12 hours ago
0
2
ADA: Once-weekly cagrilintide + semaglutide promising in type 2 diabetes
Once-weekly cagrilintide, an amylin receptor agonist, plus semaglutide is efficacious for adults with type 2 diabetes inadequately controlled with diet and exercise, receiving metformin with or without a sodium glucose cotransporter ...
Jun 12, 2026
0
6
Why drinking alcohol makes you reach for chips and nachos
Have you ever wondered why savory foods like chips, nachos and salted nuts go so well with a beer or glass of wine? And why sometimes you feel an insatiable appetite for junk food while drinking?
Jun 12, 2026
0
7
Chile's food warning labels and ad bans cut child obesity risk, analysis suggests
Chile's complementary set of policies targeting food products high in fat, salt and sugar plausibly reduces the risk of school-age children being overweight or having obesity, finds a study published in The Lancet.
Jun 11, 2026
0
5
Consuming a moderate amount of carbs could lower cardiovascular risk while also keeping 'bad' cholesterol down
Many people cross bread, pasta and potatoes off their menus, hoping to drop pounds and improve their heart health. But there's a controversy behind this multibillion-dollar wellness phenomenon: Research is divided on carbohydrate-restricted ...
Jun 11, 2026
0
9
Hip dips: What are they and can you really get rid of them?
Hip dips are having a moment. The perfectly normal indentations that sit below your hips on the outer thigh have become the latest body feature to be scrutinized, fixed and agonized over on social media. But what are they? ...
Jun 10, 2026
0
4
Once-weekly survodutide linked to drop in body weight in obesity
For adults with obesity without diabetes, once-weekly survodutide, an investigational glucagon receptor-glucagon-like peptide-1 receptor dual agonist, is associated with greater reductions in body weight than placebo, according ...
Jun 10, 2026
0
3
Injectable semaglutide shows early promise to improve fertility in women with PMOS
Researchers at the University of Colorado Anschutz have published a proof-of-concept study in Fertility and Sterility demonstrating that injectable semaglutide may offer meaningful reproductive benefits for women with polyendocrine ...
Jun 10, 2026
0
10
New GLP-3 drug significantly slashes both weight and blood sugar levels in Phase III trial
Over the past few years, GLP-1 drugs have transformed the treatment landscape for obesity and type 2 diabetes. By mimicking a hormone that helps regulate blood sugar, slows digestion and curbs appetite, these medications ...
Brain mechanism reveals how food aroma primes metabolism and may explain obesity risk
Our brain prepares the body for an incoming meal before we even take the first bite. The aroma of food simmering on the stove, for instance, can trigger the brain to send signals to the pancreas, which in turn releases insulin ...
Jun 9, 2026
0
11
Drug apitegromab may stop muscle loss when taking weight loss drugs
A drug called apitegromab may help preserve lean body mass during weight loss with tirzepatide, a GLP-1 receptor agonist, according to a phase 2 clinical trial published in Nature Medicine. The findings suggest that blocking ...
Jun 9, 2026
0
5
First-ever guideline on cardiovascular-kidney-metabolic syndrome issued
The American Heart Association and the American College of Cardiology, along with two other leading medical organizations, have developed the first-ever guideline aimed at preventing and managing cardiovascular-kidney-metabolic ...
Jun 9, 2026
0
5
Encouraging trial results for AstraZeneca's new weight-loss pill
A new pill developed by the British pharmaceutical firm AstraZeneca appears to help people lose a similar amount of weight as other oral GLP-1 drugs, trial results showed Monday.
Jun 9, 2026
0
7
Americans with severe obesity receive fewer surgeries despite rising need
Researchers from LSU's Pennington Biomedical Research Center and collaborating institutions have found that Americans with the highest levels of obesity are undergoing fewer surgical procedures overall. These procedures include ...
Jun 9, 2026
0
2
New GLP-1 oral pill lowers blood sugar and reduces bodyweight, clinical trial finds
Oral GLP-1 medications have the potential to increase access to therapies that can help lower blood sugar and reduce bodyweight. At the American Diabetes Association's Scientific Session, Mass General Brigham physician investigator ...
Jun 8, 2026
0
27
Study shows US tobacco firms used cigarette-selling tactics to globally market ultra-processed foods
A new study from the University of Kansas details how U.S. tobacco corporations expanded into global food markets from the mid-1980s to the mid-2000s, using strategies honed through cigarette sales to market ultra-processed ...
Jun 8, 2026
0
11
No, regaining weight after losing it won't permanently damage your metabolism: New research
When it comes to losing weight, the fear of "ruining your metabolism" is widespread. Indeed, many people who have lost weight and then put it back on feel that every failed attempt leaves them worse off than before, with ...
Jun 8, 2026
0
4
Weight loss treatments linked to lower risk of obesity-related cancers in people without diabetes
A study of more than 229,000 obese adults without diabetes in the United States has shown that weight loss drugs are associated with a decreased risk of obesity-related cancers. The research found that GLP-1 receptor agonists ...
Jun 7, 2026
0
11
GLP-1-based meds are linked to fewer heart events in adults with obesity, autoimmune disease
Among adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor 1 agonist (GLP-1RA) medication had lower rates of emergency department visits and were less likely to experience serious ...
Jun 6, 2026
0
8
Fasting after 60 changes more than waistlines, exposing a trade-off many dieters never see coming
Most folks know intermittent fasting helps with weight loss, usually by limiting your daily eating window or cutting calories a couple of times a week. But does your age change how well this works for you—and might there ...
Experts highlight limits of evidence from ultraprocessed food trials
A group of eating behavior and metabolism experts from across Europe have published a Perspective article in the journal Science examining the limitations of current evidence on ultraprocessed foods (UPFs).
Jun 5, 2026
0
8
'Dad bods' may influence childhood obesity risks, review suggests
As obesity rates rise across the U.S., new research from Joe C. Wen School of Population & Public Health at the University of California, Irvine scientists draws attention to an often-overlooked factor in children's long-term ...
Jun 5, 2026
1
4
It may not just be what's in ultra-processed foods, but how they're made
Concerns about the health effects of ultra-processed foods are growing, as studies increasingly link them to conditions such as heart disease, diabetes, and even early death. But scientists are still debating what's driving ...
Jun 4, 2026
0
7
